Yan Ji
Hematology & Oncology · Saint Paul, MNNPI 1225355829
Payments from drug & device makers
Across 647 payments — averaging $9804.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2.5M
- Novartis$1.7M
- Servier Bioinnovation$473K
- Genentech, Inc.$429K
- Merck$204K
- Seagen Inc.$134K
- plus $961K from 23 others
Across 3 payments — averaging $1490.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$4K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 137 | $2,461,257 |
| Novartis | 22 | $1,681,012 |
| Servier Bioinnovation | 65 | $473,311 |
| Genentech, Inc. | 102 | $429,059 |
| Merck | 24 | $203,680 |
| Seagen Inc. | 10 | $133,818 |
| Beigene, Ltd. | 73 | $128,898 |
| Astrazeneca UK Limited | 7 | $127,840 |
| Mirati Therapeutics, Inc. | 3 | $118,782 |
| AstraZeneca(2 entities) | 34 | $99,981 |
| E.r. Squibb & Sons, L.L.C. | 22 | $75,061 |
| Janssen Research & Development, LLC | 5 | $68,350 |
| Bristol Myers Squibb | 3 | $62,740 |
| Astellas Pharma Global Development | 9 | $55,549 |
| Jazz Pharmaceuticals Inc. | 27 | $53,041 |
| AbbVie | 5 | $47,820 |
| Daiichi Sankyo Inc. | 33 | $39,474 |
| Johnson & Johnson | 26 | $19,148 |
| Beone Medicines Ltd. | 12 | $17,808 |
| F. Hoffmann-la Roche AG | 3 | $16,987 |
| Janssen Scientific Affairs, LLC | 7 | $8,543 |
| Amgen | 4 | $8,100 |
| Beigene USA, Inc. | 2 | $4,550 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $3,323 |
| Beone Medicines USA, Inc. | 1 | $1,950 |
| Deciphera Pharmaceuticals Inc. | 5 | $1,841 |
| Genentech USA, Inc. | 1 | $998 |
| Novocure GmbH | 1 | $200 |
| Tempus AI, Inc | 1 | $151 |
How this compares
$6,343,270 in reported general payments places this provider in the 95th percentile of 193 hematology & oncology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Saint Paul
- Daniel AndersonSaint Paul$7.3M
- Charlene FaresSaint Paul$2.2M
- Kurt DemelSaint Paul$307K
- Sara TorgersonSaint Paul$170K
- Shilpa GuptaMinneapolis$16.3M
- Yucai WangRochester$8.2M
- Timothy LarsonMinneapolis$7.2M
- Manish PatelBloomington$6.2M
- Samith KochuparambilMinneapolis$3.3M
- Thomas AmatrudaFridley$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.